Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 20192728.
- Also identified by DOI 10.1086/651166.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The safety of high-dose oseltamivir during treatment of 2009 H1N1 influenza A infection for critically ill patients is unknown. Here we report on a case patient with severe, delayed-onset neuropsychiatric symptoms after administration of high-dose oseltamivir. Clinicians should be vigilant to the possible increased risk of complications associated with high-dose oseltamivir therapy for 2009 H1N1 influenza A infection.
Medical subject headings
- Antiviral Agents
- Influenza A Virus, H1N1 Subtype
- Influenza, Human
- Neurotoxicity Syndromes
- Oseltamivir